PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Aralen (Chloroquine)- FDA 19 Drug Drug Acetaminophen (Tylenol)- FDA 69 1 0.03 -0.97 0.05 0.79
4-Mercaptopyridine 96 Drug Drug 4-Mercaptobenzoic Acid 70 2 0.02 -0.98 0.03 0.79
Nausea 42,627 Disease Disease Headache 50,687 6,095 0.13 -0.87 0.14 0.79
Bivalirudin 891 Target Target Eptifibatide 772 36 0.04 -0.96 0.05 0.79
Anxiety 113,510 Disease Disease Anxiety Disorder 8,985 8,985 0.28 -0.01 1.00 0.79
Angiomax (Bivalirudin)- FDA 13 Drug Target Bivalirudin 891 12 0.11 -0.28 0.92 0.79
5-Hydroxytryptamine 2b Receptor 18 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.03 -0.96 0.06 0.79
CCL5 2,002 Target Target CXCL11 526 75 0.07 -0.91 0.14 0.79
Alpha-Glucosidase 4,319 Target Target Lysosomal Alpha-Glucosidase 105 105 0.16 -0.10 1.00 0.79
CAPG 85 Target Drug Kabiramide C 7 1 0.04 -0.92 0.14 0.79
AMAC-1 19 Target Target CCL18 256 4 0.06 -0.88 0.21 0.79
Acyclovir (Zovirax)- FDA 50 Drug Drug Amantadine Hydrochloride (Symmetrel)- FDA 47 1 0.02 -0.98 0.02 0.79
Adefovir Dipivoxil (Hepsera)- FDA 22 Drug Drug Abacavir Sulfate (Ziagen)- FDA 61 1 0.03 -0.97 0.05 0.79
Parkinsonism 13,164 Disease Disease Tremor 14,317 1,307 0.10 -0.90 0.10 0.79
Aurora B kinase 415 Target Target Aurora A kinase 318 14 0.04 -0.96 0.04 0.79
Draflazine 33 Drug Target Ent2 108 2 0.03 -0.96 0.06 0.79
APOA1 958 Target Target APOA2 118 25 0.07 -0.88 0.21 0.79
CXCL7 76 Target Target CXCL4/PF4 9 1 0.04 -0.94 0.11 0.79
CCL4 5,638 Target Target CCL5 2,002 316 0.09 -0.89 0.16 0.79
Draflazine 33 Drug Target Equilibrative Nucleoside Transporter 1 211 4 0.05 -0.93 0.12 0.79
CCL18 256 Target Target CCL14 34 5 0.05 -0.91 0.15 0.79
EPHA3 140 Target Target EPHB2 385 11 0.05 -0.95 0.08 0.79
Sleep Disorders 6,847 Disease Disease Narcolepsy 3,209 451 0.10 -0.90 0.14 0.79
Avastin (Bevacizumab)- FDA 207 Drug Drug Axitinib (Inlyta)- FDA 10 3 0.07 -0.83 0.30 0.79
Seborrhea 430 Disease Disease Dandruff 360 16 0.04 -0.96 0.04 0.79
CCL8 197 Target Target CXCL2 750 24 0.06 -0.92 0.12 0.79
EPHA4 357 Target Target EPHB3 118 10 0.05 -0.94 0.08 0.79
bFGF 9,327 Target Target aFGF 899 448 0.15 -0.69 0.50 0.79
CXCL11 526 Target Target CCL8 197 17 0.05 -0.94 0.09 0.79
ELC 355 Target Target Exodus-3 8 5 0.09 -0.61 0.62 0.79
Adalimumab (Humira)- FDA 62 Drug Drug Acitretin (Soriatane)- FDA 13 1 0.04 -0.95 0.08 0.79
CCL7 274 Target Target CCL3 1,427 51 0.08 -0.89 0.19 0.79
ELC 355 Target Target Exodus-2 27 7 0.07 -0.85 0.26 0.79
CCL18 256 Target Target CCL1 220 9 0.04 -0.96 0.04 0.80
CCL7 274 Target Target CCL14 34 6 0.06 -0.90 0.18 0.80
Diaper Rash 155 Disease Disease Cradle Cap 21 3 0.05 -0.92 0.14 0.80
Avandia (Rosiglitazone Maleate)- FDA 66 Drug Drug Alprazolam (Xanax)- FDA 8 1 0.04 -0.93 0.12 0.80
Acamprosate Calcium (Campral)- FDA 30 Drug Drug Amantadine Hydrochloride (Symmetrel)- FDA 47 1 0.03 -0.97 0.03 0.80
CAMK2A 42 Target Target CAMK4 43 1 0.02 -0.98 0.02 0.80
Argatroban (Argatroban Injection)- FDA 1 Drug Drug Alteplase (Activase)- FDA 112 1 0.09 -0.70 1.00 0.80
Argatroban (Argatroban Injection)- FDA 1 Drug Drug Activase (Alteplase)- FDA 112 1 0.09 -0.70 1.00 0.80
Argatroban Injection (Argatroban)- FDA 1 Drug Drug Alteplase (Activase)- FDA 112 1 0.09 -0.70 1.00 0.80
Argatroban Injection (Argatroban)- FDA 1 Drug Drug Activase (Alteplase)- FDA 112 1 0.09 -0.70 1.00 0.80
Separation Anxiety 1,096 Disease Disease Anxiety Disorder 8,985 482 0.15 -0.73 0.44 0.80
Anakinra (Kineret)- FDA 10 Drug Drug Adalimumab (Humira)- FDA 62 1 0.04 -0.94 0.10 0.80
EPHB4 329 Target Target EPHA2 532 21 0.05 -0.95 0.06 0.80
Constipation 15,810 Disease Disease Irritable Bowel Syndrome 8,230 1,425 0.12 -0.87 0.17 0.80
Sacroiliac Joint Pain 133 Disease Disease Joint Pain 4,215 133 0.18 -0.09 1.00 0.80
Atorvastatin Calcium (Lipitor)- FDA 28 Drug Drug Amantadine Hydrochloride (Symmetrel)- FDA 47 1 0.03 -0.97 0.04 0.80
Amlodipine Besylate (Norvasc)- FDA 28 Drug Drug Amantadine Hydrochloride (Symmetrel)- FDA 47 1 0.03 -0.97 0.04 0.80